サンプル依頼リスト カート
  • English
  • Korean
表紙：産後うつ病の世界市場レポート 2024年
市場調査レポート
商品コード
1415771

産後うつ病の世界市場レポート 2024年

Postpartum Depression Global Market Report 2024
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
産後うつ病の世界市場レポート 2024年
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

産後うつ病の市場規模は近年急激に拡大しています。2023年の91億7,000万米ドルから、2024年には年間平均成長率（CAGR）32.5％で121億5,000万米ドルに成長します。この実績期間の成長は、妊産婦のメンタルヘルスに対する認識、調査の進歩、公衆衛生への取り組み、スクリーニングの増加に起因しています。

産後うつ病症例の急増は、当面の産後うつ病市場成長の原動力となると思われます。産後うつ病は、不安の高まりを特徴とし、しばしば身体的症状を伴う病態で、典型的には出産後に出現します。産後うつ病は、産後うつ病や産後不安症を併発することが多く、産後1年間のどの時点でも発症する可能性があります。産後うつ病の治療には、トークセラピーやメンタルヘルス・カウンセリングを含む精神療法、薬物療法、またはその両方の組み合わせが用いられることが多く、市場の拡大に寄与しています。例えば、2022年5月、UVAメディカルセンターは、米国では2020年12月から2021年3月の間に産後うつ病症状の割合が着実に7.7％増加したと報告しました。さらに2021年には、米国50州のうち36州とコロンビア特別区で産後うつ病症状が増加しました。その結果、産後うつ病症例の増加が産後うつ病市場を促進すると予想されます。

2023年の産後うつ病市場で最大の地域は北米でした。産後うつ病レポートがカバーしている地域は、アジア太平洋、西欧、中東欧、北米、南米、中東・アフリカです。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 世界の市場促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の市場規模実績と成長、2018年～2023年
  • 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

  • 世界の産後うつ病市場、タイプ別セグメンテーション、実績および予測、2018-2023、2023-2028年、2033年
  • 産後ブルース
  • 産後の不安
  • 産後強迫性障害
  • 産後パニック障害
  • 産後心的外傷後ストレス障害
  • 産後精神病
  • その他のタイプ
  • 世界の産後うつ病市場、治療別セグメンテーション、実績および予測、2018-2023、2023-2028年、2033年
  • 心理療法
  • 薬剤
  • サプリメント
  • その他の治療法
  • 世界の産後うつ病市場、投与経路別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 経口
  • 非経口
  • その他の投与経路
  • 世界の産後うつ病市場、流通チャネル別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 病院薬局
  • 小売薬局
  • オンライン薬局
  • その他の流通チャネル
  • 世界の産後うつ病市場、エンドユーザー別セグメンテーション、実績および予測、2018-2023、2023-2028年、2033年
  • 病院
  • 専門クリニック
  • 在宅ケア
  • その他のエンドユーザー

第7章 地域および国の分析

  • 世界の産後うつ病市場、地域別、実績および予測、2018-2023、2023-2028年、2033年
  • 世界の産後うつ病市場、国別、実績および予測、2018-2023、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 産後うつ病市場の競合情勢
  • 産後うつ病市場の企業プロファイル
    • Pfizer Inc.
    • Johnson &Johnson
    • Roche Holding AG
    • Merck &Co.
    • AbbVie Inc.

第31章 その他の主要および革新的な企業

  • Novartis AG
  • Sanofi SA
  • Bristol Myers Squibb Co.
  • AstraZeneca plc
  • GlaxoSmithKline LLC
  • Takeda Pharmaceutical Company
  • Eli Lilly and Company
  • Gilead Sciences Inc.
  • Amgen Inc.
  • Moderna Inc.
  • BioNTech SE
  • Viatris Inc.
  • Northwell Health
  • Teva Pharmaceutical Industries Ltd.
  • Regeneron Pharmaceuticals Inc.

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

目次
Product Code: r12370

“Postpartum Depression Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on postpartum depression market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for postpartum depression? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The postpartum depression market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Types: Postpartum Blues; Postpartum Anxiety; Postpartum Obsessive Compulsive Disorder; Postpartum Panic Disorder; Postpartum Post-Traumatic Stress Disorder; Postpartum Psychosis; Other Types
  • 2) By Treatment: Psychotherapy; Medication; Supplements; Other Treatments
  • 3) By Route of Administration: Oral; Parenteral; Other Route Of Administration
  • 4) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy; Other Distribution Channels
  • 5) End-Users: Hospitals; Specialty Clinics; Homecare; Other End-Users
  • Companies Mentioned: Pfizer Inc.; Johnson & Johnson; Roche Holding AG; Merck & Co.; AbbVie Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Postpartum depression (PPD) is a mood disorder that affects some women after giving birth and often goes undiagnosed for extended periods. It is characterized by feelings of sadness, hopelessness, and a loss of interest or pleasure in activities once enjoyed.

The main types of postpartum depression include postpartum blues, postpartum anxiety, postpartum obsessive-compulsive disorder, postpartum panic disorder, postpartum post-traumatic stress disorder, postpartum psychosis, and others. Postpartum blues is a common but self-limiting condition that occurs shortly after childbirth, featuring symptoms such as mood swings, irritability, and tearfulness. Treatment for postpartum depression involves various approaches, including psychotherapy, medication, supplements, and other therapeutic interventions. These treatments can be administered in different ways, such as orally, through injections, and more. Postpartum depression remedies are available through various distribution channels, including hospital pharmacies, retail pharmacies, online pharmacies, and others. They are used by a range of end-users, including hospitals, specialty clinics, home-care settings, and others.

The postpartum depression market research report is one of a series of new reports from The Business Research Company that provides postpartum depression market statistics, including postpartum depression industry global market size, regional shares, competitors with a postpartum depression market share, detailed postpartum depression market segments, market trends and opportunities and any further data you may need to thrive in the postpartum depression industry. This postpartum depression market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The postpartum depression market size has grown exponentially in recent years. It will grow from $9.17 billion in 2023 to $12.15 billion in 2024 at a compound annual growth rate (CAGR) of 32.5%. The growth in the historic period can be attributed to maternal mental health awareness, research advancements, public health initiatives, increased screenings.

The postpartum depression market size is expected to see exponential growth in the next few years. It will grow to $36.96 billion in 2028 at a compound annual growth rate (CAGR) of 32.1%. The growth in the forecast period can be attributed to telehealth services, pharmacological advancements, maternal mental health legislation, mental health workforce expansion. Major trends in the forecast period include integrated care models, peer support programs, perinatal mental health apps, mental health screening tools.

The surge in postpartum depression cases is poised to be the driving force behind the growth of the postpartum depression market in the foreseeable future. Postpartum depression, a condition characterized by heightened anxiety and often accompanied by physical symptoms, typically emerges following childbirth. It is frequently concomitant with postnatal depression and postpartum anxiety and can manifest at any point during the first year after childbirth. Treatment for postpartum depression often involves psychotherapy, which includes talk therapy or mental health counseling, medication, or a combination of both, contributing to the market's expansion. For example, in May 2022, UVA Medical Center reported that the United States witnessed a steady 7.7% increase in the rates of postpartum depression symptoms between December 2020 and March 2021. Furthermore, in 2021, postpartum depression symptoms escalated in 36 out of the 50 U.S. states as well as the District of Columbia. Consequently, the rise in postpartum depression cases is expected to propel the postpartum depression market.

The burgeoning number of childbirths is anticipated to drive the growth of the postpartum depression market. Childbirth refers to the process of delivering a baby from the mother's uterus, typically through the vaginal canal. The mounting number of childbirths plays a pivotal role in the postpartum depression market since postpartum depression (PPD) is a prevalent mental health condition that can affect women after giving birth. This condition manifests through a broad spectrum of symptoms, including feelings of sadness, anxiety, fatigue, and challenges in forming a bond with the newborn. For instance, in August 2022, data from the Office for National Statistics revealed that in 2021, England and Wales recorded a total of 624,828 live births, marking a 1.8% increase from the 613,936 births reported in 2020. Hence, the escalating number of childbirths is a key driver behind the growth of the postpartum depression market.

The underdiagnosis of postpartum depression hinders the growth of the postpartum depression market during the forecast period. Underdiagnosing postpartum depression (PPD) presents significant challenges for women, resulting in reduced access to treatment, an increased risk of complications, diminished quality of life, added workload for healthcare providers, decreased awareness of PPD, and the perpetuation of stigma surrounding the condition. For instance, a study from January 2023 conducted by Valparaiso University found that 60% of first-time mothers in the study experienced underdiagnosed postpartum depression. Among these individuals, 49% were either frequent or occasional alcohol consumers, and 57% were active smokers during their pregnancy. Therefore, underdiagnosis is a hindrance to the growth of the postpartum depression market.

Companies active in the postpartum depression market are focusing on innovation to maintain their market presence. The need for faster-acting therapies and innovative care delivery methods for postpartum depression has arisen due to the limited treatment options available. For example, in February 2023, Biogen Inc., a U.S.-based biotechnology company, and Sage Therapeutics Inc., a U.S.-based biopharmaceutical company, announced the acceptance of a new drug application (NDA) by the United States Food and Drug Administration (FDA) for zuranolone in the treatment of major depressive disorder (MDD) and postpartum depression (PPD). Zuranolone is an experimental medication being investigated as a 14-day, once-daily, fast-acting oral therapy for individuals with MDD and PPD. As a neuroactive steroid, zuranolone functions as a positive allosteric modulator of GABA-A receptors, offering a unique mechanism of action. It is designed to rapidly reset dysregulated neural networks to aid in restoring brain function and, in turn, influence the brain networks responsible for mood, arousal, behavior, and cognition.

In December 2022, Biogen Inc. and Sage Therapeutics Inc. joined forces for an undisclosed amount, aimed at the development and commercialization of drugs for major depressive disorder (MDD), postpartum depression (PPD), as well as other mental disorders, essential tremor, and various neurological conditions. Sage Therapeutics Inc. specializes in the development of therapies for neurological conditions such as depression, PPD, neurology, and neuropsychiatric disorders. This collaboration enhances the prospects for advancing treatments in the field of mental health and neurology.

Major players in the postpartum depression market are Pfizer Inc., Johnson & Johnson, Roche Holding AG, Merck & Co., AbbVie Inc., Novartis AG, Sanofi SA, Bristol Myers Squibb Co., AstraZeneca PLC, GlaxoSmithKline LLC, Takeda Pharmaceutical Company, Eli Lilly and Company, Gilead Sciences Inc., Amgen Inc., Moderna Inc., BioNTech SE, Viatris Inc., Northwell Health, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Lupin Pharmaceuticals, Mallinckrodt Pharmaceuticals PLC, Sage Therapeutics Inc.

North America was the largest region in the postpartum depression market in 2023. The regions covered in postpartum depression report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the postpartum depression market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, and Spain.

The postpartum depression market consists of revenues earned by entities by providing services such as medications, psychotherapy (cognitive behavioral therapy) and support group participation. The market value includes the value of related goods sold by the service provider or included within the service offering. The postpartum depression market also includes the sales of medications such as Selective serotonin reuptake inhibitors (SSRIs), Serotonin and norepinephrine reuptake inhibitors (SNRIs), Bupropion and Tricyclic antidepressants (TCAs). Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Postpartum Depression Market Characteristics

3. Postpartum Depression Market Trends And Strategies

4. Postpartum Depression Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Postpartum Depression Market Size and Growth

  • 5.1. Global Postpartum Depression Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Postpartum Depression Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Postpartum Depression Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Postpartum Depression Market Segmentation

  • 6.1. Global Postpartum Depression Market, Segmentation By Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Postpartum Blues
  • Postpartum Anxiety
  • Postpartum Obsessive Compulsive Disorder
  • Postpartum Panic Disorder
  • Postpartum Post-Traumatic Stress Disorder
  • Postpartum Psychosis
  • Other Types
  • 6.2. Global Postpartum Depression Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Psychotherapy
  • Medication
  • Supplements
  • Other Treatments
  • 6.3. Global Postpartum Depression Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Oral
  • Parenteral
  • Other Route Of Administration
  • 6.4. Global Postpartum Depression Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
  • Other Distribution Channels
  • 6.5. Global Postpartum Depression Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Specialty Clinics
  • Homecare
  • Other End-Users

7. Postpartum Depression Market Regional And Country Analysis

  • 7.1. Global Postpartum Depression Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Postpartum Depression Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Postpartum Depression Market

  • 8.1. Asia-Pacific Postpartum Depression Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Postpartum Depression Market, Segmentation By Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Postpartum Depression Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Postpartum Depression Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Postpartum Depression Market

  • 9.1. China Postpartum Depression Market Overview
  • 9.2. China Postpartum Depression Market, Segmentation By Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Postpartum Depression Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Postpartum Depression Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Postpartum Depression Market

  • 10.1. India Postpartum Depression Market, Segmentation By Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Postpartum Depression Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Postpartum Depression Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Postpartum Depression Market

  • 11.1. Japan Postpartum Depression Market Overview
  • 11.2. Japan Postpartum Depression Market, Segmentation By Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Postpartum Depression Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Postpartum Depression Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Postpartum Depression Market

  • 12.1. Australia Postpartum Depression Market, Segmentation By Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Postpartum Depression Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Postpartum Depression Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Postpartum Depression Market

  • 13.1. Indonesia Postpartum Depression Market, Segmentation By Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Postpartum Depression Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Postpartum Depression Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Postpartum Depression Market

  • 14.1. South Korea Postpartum Depression Market Overview
  • 14.2. South Korea Postpartum Depression Market, Segmentation By Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Postpartum Depression Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Postpartum Depression Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Postpartum Depression Market

  • 15.1. Western Europe Postpartum Depression Market Overview
  • 15.2. Western Europe Postpartum Depression Market, Segmentation By Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Postpartum Depression Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Postpartum Depression Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Postpartum Depression Market

  • 16.1. UK Postpartum Depression Market, Segmentation By Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Postpartum Depression Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Postpartum Depression Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Postpartum Depression Market

  • 17.1. Germany Postpartum Depression Market, Segmentation By Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Postpartum Depression Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Postpartum Depression Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Postpartum Depression Market

  • 18.1. France Postpartum Depression Market, Segmentation By Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Postpartum Depression Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Postpartum Depression Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Postpartum Depression Market

  • 19.1. Italy Postpartum Depression Market, Segmentation By Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Postpartum Depression Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Postpartum Depression Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Postpartum Depression Market

  • 20.1. Spain Postpartum Depression Market, Segmentation By Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Postpartum Depression Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Postpartum Depression Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Postpartum Depression Market

  • 21.1. Eastern Europe Postpartum Depression Market Overview
  • 21.2. Eastern Europe Postpartum Depression Market, Segmentation By Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Postpartum Depression Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Postpartum Depression Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Postpartum Depression Market

  • 22.1. Russia Postpartum Depression Market, Segmentation By Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Postpartum Depression Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Postpartum Depression Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Postpartum Depression Market

  • 23.1. North America Postpartum Depression Market Overview
  • 23.2. North America Postpartum Depression Market, Segmentation By Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Postpartum Depression Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Postpartum Depression Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Postpartum Depression Market

  • 24.1. USA Postpartum Depression Market Overview
  • 24.2. USA Postpartum Depression Market, Segmentation By Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Postpartum Depression Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Postpartum Depression Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Postpartum Depression Market

  • 25.1. Canada Postpartum Depression Market Overview
  • 25.2. Canada Postpartum Depression Market, Segmentation By Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Postpartum Depression Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Postpartum Depression Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Postpartum Depression Market

  • 26.1. South America Postpartum Depression Market Overview
  • 26.2. South America Postpartum Depression Market, Segmentation By Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Postpartum Depression Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Postpartum Depression Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Postpartum Depression Market

  • 27.1. Brazil Postpartum Depression Market, Segmentation By Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Postpartum Depression Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Postpartum Depression Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Postpartum Depression Market

  • 28.1. Middle East Postpartum Depression Market Overview
  • 28.2. Middle East Postpartum Depression Market, Segmentation By Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Postpartum Depression Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Postpartum Depression Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Postpartum Depression Market

  • 29.1. Africa Postpartum Depression Market Overview
  • 29.2. Africa Postpartum Depression Market, Segmentation By Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Postpartum Depression Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Postpartum Depression Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Postpartum Depression Market Competitive Landscape And Company Profiles

  • 30.1. Postpartum Depression Market Competitive Landscape
  • 30.2. Postpartum Depression Market Company Profiles
    • 30.2.1. Pfizer Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Johnson & Johnson
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Roche Holding AG
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Merck & Co.
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. AbbVie Inc.
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Postpartum Depression Market Other Major And Innovative Companies

  • 31.1. Novartis AG
  • 31.2. Sanofi SA
  • 31.3. Bristol Myers Squibb Co.
  • 31.4. AstraZeneca plc
  • 31.5. GlaxoSmithKline LLC
  • 31.6. Takeda Pharmaceutical Company
  • 31.7. Eli Lilly and Company
  • 31.8. Gilead Sciences Inc.
  • 31.9. Amgen Inc.
  • 31.10. Moderna Inc.
  • 31.11. BioNTech SE
  • 31.12. Viatris Inc.
  • 31.13. Northwell Health
  • 31.14. Teva Pharmaceutical Industries Ltd.
  • 31.15. Regeneron Pharmaceuticals Inc.

32. Global Postpartum Depression Market Competitive Benchmarking

33. Global Postpartum Depression Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Postpartum Depression Market

35. Postpartum Depression Market Future Outlook and Potential Analysis

  • 35.1 Postpartum Depression Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Postpartum Depression Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Postpartum Depression Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer